{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:59:01Z","timestamp":1773269941820,"version":"3.50.1"},"publisher-location":"Cham","reference-count":37,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319299969","type":"print"},{"value":"9783319299983","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-29998-3_12","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T09:35:18Z","timestamp":1460626518000},"page":"213-226","source":"Crossref","is-referenced-by-count":1,"title":["Genetic Testing for Rare Cancer: The Wider Issues"],"prefix":"10.1007","author":[{"given":"Chris","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Pichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"12_CR1","doi-asserted-by":"crossref","unstructured":"Alexandrov BL, Nik-Zainai S, Wedge DC et al (2013) Signatures of mutational processes in human cancer. Nature 500(7463):415\u2013421","DOI":"10.1038\/nature12477"},{"key":"12_CR2","first-page":"2654","volume":"21","author":"K Alsop","year":"2014","unstructured":"Alsop K, Fereday S, Meldrum C et al (2014) BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: A report from the Australian ovarian cancer study group. J Clin Oncol 21:2654\u20132663","journal-title":"J Clin Oncol"},{"key":"12_CR3","first-page":"240","volume":"27","author":"ASHG","year":"1975","unstructured":"ASHG (1975) Genetic counseling. Am J Hum Genet 27:240\u2013242","journal-title":"Am J Hum Genet"},{"issue":"10","key":"12_CR4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ejhg.2012.297","volume":"21","author":"Carmen Ayuso","year":"2013","unstructured":"Ayuso C, Millan J, Mancheno M, Dal-Re R (2013) Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process. Eur J Hum Genet 21(10):1054\u20131059","journal-title":"European Journal of Human Genetics"},{"issue":"1","key":"12_CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajhg.2015.05.022","volume":"97","author":"Jeffrey\u00a0R. Botkin","year":"2015","unstructured":"Botkin JR, Belmont JW, Berg JS et al (2015) Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 97(1):6\u201321","journal-title":"The American Journal of Human Genetics"},{"key":"12_CR6","unstructured":"British Society for Human Genetics (2010) Report on the genetic testing of children 2010. British Society for Human Genetics"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S1474-4422(15)70003-7","volume":"14","author":"A Burton","year":"2015","unstructured":"Burton A (2015) Are we ready for direct-to-consumer genetic testing? Lancet Neurol 14:138\u2013139","journal-title":"Lancet Neurol"},{"issue":"4","key":"12_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s10897-010-9296-y","volume":"19","author":"K Chivers Seymour","year":"2010","unstructured":"Chivers Seymour K, Addlington-Hall J, Lucassen AM, Foster CL (2010) What facilitates or impedes family communication following genetic testing for cancer risk? A systematic review and meta-synthesis of primary qualitative research. J Genet Couns 19(4):330\u2013342","journal-title":"J Genet Couns"},{"issue":"3","key":"12_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cge.12354","volume":"86","author":"G.M. Christenhusz","year":"2014","unstructured":"Chrisitenhusz GM, Devriendt K, Peeters H et al (2014) The communication of secondary variants: interviews with parents whose children have undergone array-CHG testing Clin Genet 86(3):207\u2013216","journal-title":"Clinical Genetics"},{"issue":"1","key":"12_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10689-009-9260-x","volume":"9","author":"A Clarke","year":"2010","unstructured":"Clarke A (2010) What is at stake in the predictive genetic testing of children? (2010). Fam Cancer 9(1):19\u201322","journal-title":"Fam Cancer"},{"issue":"9","key":"12_CR11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/GIM.0b013e3181ab2295","volume":"11","author":"Molly S Daniels","year":"2009","unstructured":"Daniels MS, Urbauer DL, Stanley JL et al (2009) Timing of BRCA1\/BRCA2 genetic testing in women with ovarian cancer. Genet Med 11(9):624\u2013628","journal-title":"Genetics in Medicine"},{"issue":"4","key":"12_CR12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1034\/j.1399-0004.2003.00142.x","volume":"64","author":"K Forrest","year":"2003","unstructured":"Forrest K, Simpson SA, Wilson BJ et al (2003) To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 64(4):317\u2013326","journal-title":"Clinical Genetics"},{"issue":"3","key":"12_CR13","first-page":"173","volume":"2","author":"L Godino","year":"2012","unstructured":"Godino L, Skirton H (2012) A systematic review of nurses\u2019 knowledge of genetics. J Nurs Educ Pract 2(3):173\u2013184","journal-title":"J Nurs Educ Pract"},{"issue":"7","key":"12_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green RC, Berg JS, Grody WW et al (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15(7):565\u2013574","journal-title":"Genet Med"},{"issue":"9","key":"12_CR15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1542-3565(04)00352-0","volume":"2","author":"Shilpa Grover","year":"2004","unstructured":"Grover S, Stoffel EM, Bussone L et al (2004) Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2(9):813\u2013819","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3","key":"12_CR16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.socscimed.2003.11.025","volume":"59","author":"N Hallowell","year":"2004","unstructured":"Hallowell N, Foster C, Eeles R et al (2004) Accommodating risk: responses to BRCA1\/2 genetic testing of women who have had cancer. Soc Sci Med 59(3):553\u2013565","journal-title":"Social Science & Medicine"},{"key":"12_CR17","unstructured":"House of Lords Science and Technology Committee (2009) Genomic medicine, 7 July"},{"issue":"2","key":"12_CR18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ajmg.10110","volume":"107","author":"Chanita Hughes","year":"2002","unstructured":"Hughes C, Lerman C, Schwartz M et al (2002) All in the family: evaluation of the process and content of sisters\u2019 communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 107(2):143\u2013150","journal-title":"American Journal of Medical Genetics"},{"issue":"3","key":"12_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ctrv.2012.04.008","volume":"39","author":"SA Hurvitz","year":"2013","unstructured":"Hurvitz SA, Hu Y, O\u2019Brien N, Finn RS (2013) Current approaches and future directions in the treatment of HER2-positive breast cancer. Cancer Treat Rev 39(3):219\u2013229","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"12_CR20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0959-8049(98)00164-6","volume":"34","author":"C. Julian-Reynier","year":"1998","unstructured":"Julian-Reynier C, Eisinger F, Chabal F et al (1998) Cancer genetic clinics: why do women who already have cancer attend? Eur J Cancer 34(10):1549\u20131553","journal-title":"European Journal of Cancer"},{"issue":"2","key":"12_CR21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/IGC.0b013e3182392714","volume":"22","author":"Anne Lanceley","year":"2012","unstructured":"Lanceley A, Eagle Z, Ogden G et al (2012) Family history and women with ovarian cancer: is it asked and does it matter?: an observational study. Int J Gynecol Cancer 22(2):254\u2013259","journal-title":"International Journal of Gynecological Cancer"},{"issue":"12","key":"12_CR22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pon.933","volume":"14","author":"Bettina Meiser","year":"2005","unstructured":"Meiser B (2005) Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 14(12):1060\u20131074","journal-title":"Psycho-Oncology"},{"issue":"1-2","key":"12_CR23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2702.2009.02935.x","volume":"19","author":"Alison Metcalfe","year":"2010","unstructured":"Metcalfe A, Pumphrey R, Clifford C (2010) Hospice nurses and genetics: implications for end-of-life care. J Clin Nurs 19(1\u20132):192\u2013207","journal-title":"Journal of Clinical Nursing"},{"issue":"5","key":"12_CR24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/AOG.0b013e3181da08d7","volume":"115","author":"Larissa A. Meyer","year":"2010","unstructured":"Meyer LA, Anderson ME, Lacour RA et al (2010) Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol 115(5):945\u2013952","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"12_CR25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajmg.a.20200","volume":"119A","author":"Susan Michie","year":"2003","unstructured":"Michie S, Smith JA, Senior V, Marteau TM et al (2003) Understanding why negative genetic test results sometimes fail to reassure. Am J Med Genet A 119A(3):340\u2013347","journal-title":"American Journal of Medical Genetics"},{"key":"12_CR26","unstructured":"National Institute for Health and Care Excellence (2013) Familial Breast Cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer CG164, London"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature12981","volume":"505","author":"N Rahman","year":"2014","unstructured":"Rahman N (2014a) Realizing the promise of cancer predisposition genes. Nature 505:302\u2013308","journal-title":"Nature"},{"issue":"4","key":"12_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.7861\/clinmedicine.14-4-436","volume":"14","author":"N Rahman","year":"2014","unstructured":"Rahman N (2014b) Mainstreaming genetic testing of cancer predisposition genes. Clin Med 14(4):436\u2013439","journal-title":"Clin Med"},{"key":"12_CR29","doi-asserted-by":"crossref","unstructured":"Robson ME, Bradbury AR, Arun B et al (2015) American Society of Clinical Oncology Policy Statement Update: genetic and genomic testing for cancer susceptibility. J Clin Oncol (Aug 31)","DOI":"10.1200\/JCO.2015.63.0996"},{"key":"12_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2015.07.010","volume":"100","author":"RJR Roskoski","year":"2015","unstructured":"Roskoski RJR (2015) A historical overview of protein kinases and their targeted small molecule inhibitors. Pharmacol Res 100:1\u201323","journal-title":"Pharmacol Res"},{"key":"12_CR31","unstructured":"Royal College of Physicians Royal College of Pathologists and British Society for Human Genetics (2011) Consent and confidentiality in clinical genetic practice: guidance on genetic testing and sharing genetic information, 2nd edn. Report of the Joint Committee on Medical Genetics, London"},{"key":"12_CR32","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1001\/jama.299.11.1320","volume":"299","author":"M Scheuner","year":"2008","unstructured":"Scheuner M, Sieverding P, Shekelle P (2008) Delivery of genomic medicine for common chronic adult diseases: a systematic review. J Am Med Assoc 299:1320\u20131334","journal-title":"J Am Med Assoc"},{"issue":"12","key":"12_CR33","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1200\/JCO.2014.58.8848","volume":"33","author":"CL Scott","year":"2015","unstructured":"Scott CL, Swisher EM, Kaufmann SH (2015) Poly (ADP-ribose) polymerase inhibitors: recent advances and future development. J Clin Oncol 33(12):1397\u20131406","journal-title":"J Clin Oncol"},{"issue":"715","key":"12_CR34","first-page":"723","volume":"51","author":"S Shked-Rafid","year":"2014","unstructured":"Shked-Rafid S, Dheensa S, Crawford G et al (2014) Defining and managing incidental findings in genetic and genomic practice. J Med Genet 51(715):723 (Published online 16.09.14)","journal-title":"J Med Genet"},{"issue":"2","key":"12_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/cpt.210","volume":"97","author":"T Hohlfeld","year":"2014","unstructured":"Thomas F, Hennebelle I, Delmas C et al (2015) Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil\/uracil ratio. Clin Pharmacol Ther. doi:\n                  10.1002\/cpt.210\n                  \n                 [Epub ahead of print]","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"12_CR36","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/gtmb.2009.0029","volume":"13","author":"F Vansenne","year":"2009","unstructured":"Vansenne F, Bossuyt PM, de Borgie CA (2009) Evaluating the psychological effects of genetic testing in symptomatic patients: a systematic review. Genet Test Mol Biomarkers 13:555\u2013563","journal-title":"Genet Test Mol Biomarkers"},{"key":"12_CR37","doi-asserted-by":"crossref","unstructured":"Wright CF, Middleton A, Burton H (2013) Policy challenges of clinical genome sequencing. BMJ 2013:347\u2013353","DOI":"10.1136\/bmj.f6845"}],"container-title":["Recent Results in Cancer Research","Rare Hereditary Cancers"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-29998-3_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:17:35Z","timestamp":1559434655000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-29998-3_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319299969","9783319299983"],"references-count":37,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-29998-3_12","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}